These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6151595)

  • 1. Potential inhibitors of tyrosine hydroxylase and dopamine-beta-hydroxylase.
    Scott KR; Alt CJ; Kemp M; Hayes E; Telang VG
    J Pharm Sci; 1984 Nov; 73(11):1531-5. PubMed ID: 6151595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine hydroxylase and dopamine beta-hydroxylase inhibiting properties of a new series of pyridazinyl hydrazones.
    Huszti Z; Szilágyi G; Kasztreiner E
    Biochem Pharmacol; 1983 Feb; 32(4):627-36. PubMed ID: 6131675
    [No Abstract]   [Full Text] [Related]  

  • 3. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
    Farnebo LO; Hamberger B; Jonsson G
    J Neurochem; 1971 Dec; 18(12):2491-500. PubMed ID: 4400156
    [No Abstract]   [Full Text] [Related]  

  • 4. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of various inhibitors of tyrosine hydroxylase and dopamine beta-hydroxylase on rat self-stimulation after reserpine treatment.
    Stinus L; Thierry AM; Cardo B
    Psychopharmacologia; 1976 Feb; 45(3):287-94. PubMed ID: 2944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of catecholamine synthesis during ontogenic development.
    Kellogg C; Lundborg P
    Brain Res; 1973 Oct; 61():321-9. PubMed ID: 4149305
    [No Abstract]   [Full Text] [Related]  

  • 7. Some catecholamine inhibitors do not cause accumulation of nuclear estrogen receptors in rat hypothalamus and anterior pituitary gland.
    Blaustein JD; Brown TJ; McElroy JF
    Neuroendocrinology; 1986; 43(2):143-9. PubMed ID: 2873523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catecholeamine biosynthesis in the mollusk Helix pomatia. In vitro demonstration of tyrosine hydroxylase and dopamine-beta-hydroxylase].
    Cardot J
    C R Acad Hebd Seances Acad Sci D; 1973 Oct; 277(15):1529-32. PubMed ID: 4149725
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition by hydralazine of catecholamine biosynthesis in cultured bovine adrenal medullary cells.
    Houchi H; Morita K; Minakuchi K; Oka M
    Biochem Pharmacol; 1986 Jun; 35(12):2047-9. PubMed ID: 2872897
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of disulfiram and sodium diethyldithiocarbamate on tyrosine and dopamine-beta-hydroxylases activities in rat brain and heart.
    Szmigielski A
    Pol J Pharmacol Pharm; 1975; 27(2):153-9. PubMed ID: 239395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of norepinephrine levels, tyrosine hydroxylase and dopamine-beta-hydroxylase activities after castration and testosterone treatment in vas deferens of adult rats.
    Bustamante D; Lara H; Belmar J
    Biol Reprod; 1989 Mar; 40(3):541-8. PubMed ID: 2569330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S
    Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
    [No Abstract]   [Full Text] [Related]  

  • 14. The occurrence and functional significance of dopamine in some peripheral adrenergic nerves of the rat.
    Snider SR; Almgren O; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(1):1-12. PubMed ID: 4145469
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of tyrosine hydroxylase inhibition on the action of 6-hydroxydopamine.
    Jonsson G; Sachs C
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):287-96. PubMed ID: 4144667
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis of noradrenaline in isolated rat iris during field stimulation.
    Farnebo LO; Lidbrink P
    Acta Physiol Scand Suppl; 1971; 371():29-34. PubMed ID: 4402148
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors.
    Andén NE; Corrodi H; Fuxe K
    J Pharm Pharmacol; 1972 Mar; 24(3):177-82. PubMed ID: 4402775
    [No Abstract]   [Full Text] [Related]  

  • 18. The Role of the Brain in the Regulation of Peripheral Organs-Noradrenaline Sources in Neonatal Rats: Noradrenaline Synthesis Enzyme Activity.
    Murtazina AR; Nikishina YO; Ugrumov MV
    Dokl Biochem Biophys; 2020 Jul; 493(1):201-204. PubMed ID: 32894465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional disappearance of catecholamines formed from 14 C-tyrosine in rat brain: effect of synthesis inhibitors and of chlorpromazine.
    Nybäck H
    Acta Pharmacol Toxicol (Copenh); 1971; 30(5):372-84. PubMed ID: 4401187
    [No Abstract]   [Full Text] [Related]  

  • 20. The biosynthesis of octopamine.
    Brandau K; Axelrod J
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):123-33. PubMed ID: 4402467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.